These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction. Sartipy U; Dahlström U; Fu M; Lund LH JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451 [TBL] [Abstract][Full Text] [Related]
9. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. Lund LH; Claggett B; Liu J; Lam CS; Jhund PS; Rosano GM; Swedberg K; Yusuf S; Granger CB; Pfeffer MA; McMurray JJV; Solomon SD Eur J Heart Fail; 2018 Aug; 20(8):1230-1239. PubMed ID: 29431256 [TBL] [Abstract][Full Text] [Related]
10. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China]. Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275 [No Abstract] [Full Text] [Related]
11. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction. Chen X; Savarese G; Dahlström U; Lund LH; Fu M Clin Res Cardiol; 2019 Dec; 108(12):1394-1405. PubMed ID: 30980205 [TBL] [Abstract][Full Text] [Related]
12. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Rickenbacher P; Kaufmann BA; Maeder MT; Bernheim A; Goetschalckx K; Pfister O; Pfisterer M; Brunner-La Rocca HP; Eur J Heart Fail; 2017 Dec; 19(12):1586-1596. PubMed ID: 28295985 [TBL] [Abstract][Full Text] [Related]
13. Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction. Rovai S; Corrà U; Piepoli M; Vignati C; Salvioni E; Bonomi A; Mattavelli I; Arcari L; Scardovi AB; Perrone Filardi P; Lagioia R; Paolillo S; Magrì D; Limongelli G; Metra M; Senni M; Scrutinio D; Raimondo R; Emdin M; Lombardi C; Cattadori G; Parati G; Re F; Cicoira M; Villani GQ; Minà C; Correale M; Frigerio M; Perna E; Mapelli M; Magini A; Clemenza F; Bussotti M; Battaia E; Guazzi M; Bandera F; Badagliacca R; Di Lenarda A; Pacileo G; Maggioni A; Passino C; Sciomer S; Sinagra G; Agostoni P; Eur J Heart Fail; 2019 Dec; 21(12):1586-1595. PubMed ID: 31782225 [TBL] [Abstract][Full Text] [Related]
14. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry. Yoshikawa Y; Tamaki Y; Morimoto T; Yaku H; Yamamoto E; Inuzuka Y; Ozasa N; Kitai T; Nagao K; Sato Y; Kondo H; Tamura T; Nakagawa Y; Kuwahara K; Kato T; Kimura T PLoS One; 2020; 15(9):e0239100. PubMed ID: 32925953 [TBL] [Abstract][Full Text] [Related]
15. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction. Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801 [TBL] [Abstract][Full Text] [Related]
16. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study. Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895 [TBL] [Abstract][Full Text] [Related]
17. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002 [TBL] [Abstract][Full Text] [Related]
18. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial. Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China. Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]